CTEV · NYSE
Claritev Corporation
$22.56 -0.12 (-0.53%)
Company overview
Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs through data-driven algorithms and insights that detect claims overcharges and negotiate or recommend reimbursement, as well as network-based services that provide contracted discounts with healthcare providers and outsourced network development and management services. It provides payment and revenue integrity services, such as identifying and removing improper and unnecessary charges paid during the claim, as well as services to identify and help restore and preserve underpaid premium dollars.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Exchange
- NYSE
- Market cap
- $382M
- Employees
- 2,700
- Headquarters
- New York City, NY
- Website
- claritev.com
- CEO
- Travis S. Dalton
- Listed
- April 3, 2020
- P/E
- -1.30
- Dividend yield
- 0.00%
Company financials
- Revenue
- $979M
- Gross profit
- $598M
- Operating income
- $42M
- EBITDA
- $519M
- Net income
- -$287M
- EPS
- -$17.33
- Total assets
- $4.8B
- Total debt
- $4.6B
- Gross margin
- 61.06%
- Net margin
- -29.27%
- Earnings yield
- -76.82%
No geographic segmentation.
Showing FY 2025
CTEV
1D
NYSE
O21.86H22.92L20.97C22.68+1.14 (+5.29%)Vol60.58K